Discover
CAMP
CAMP4 THERAPEUTICS CORPORATION
3.77
2 x 2.94
2 x 5.46
bid
ask
+
0.07
1.89%
2 @ 04:01 PM
3.77 +0.00 (0.00%)
| Ytd | -38.50% | |
| 1y | -0.53% |
3.62
day range
3.86
2.90
52 week range
7.13
| Open | 3.70 | Prev Close | 3.70 | Low | 3.62 | High | 3.86 | Mkt Cap | 236.58M |
| Vol | 72.15K | Avg Vol | 279.32K | EPS | -2.32 | P/E | N/A | Forward P/E | -2.52 |
| Beta | 0.27 | Short Ratio | 2.72 | Inst. Own | 42.04% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 4.18 | 200-d Avg | 4.42 | 1yr Est | 19.91 |
CAMP News
benzinga.com
Chardan Capital Maintains Buy on Camp4 Therapeutics, Lowers Price Target to $6
Chardan Capital analyst Keay Nakae maintains Camp4 Therapeutics (NASDAQ:CAMP) with a Buy and lowe
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) shares rose 25.3% to $2.08 during Friday's afte
benzinga.com
CAMP4 Therapeutics Receives MHRA Authorization To Include UK Sites In Global Phase 1/2 Clinical Tria
Authorization from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) builds on